Skip to main content
Erschienen in: Infection 2/2013

01.04.2013 | Clinical and Epidemiological Study

Conversion rates of an interferon-γ release assay and the tuberculin skin test in the serial monitoring of healthcare workers

verfasst von: S. Y. Kim, M. S. Park, Y. S. Kim, S. K. Kim, J. Chang, Y. A. Kang

Erschienen in: Infection | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Regular monitoring of latent tuberculosis (TB) infection in healthcare workers (HCWs) is recommended, but the view about the effective method and performance of serial monitoring is controversial. The aim of this study was to determine differences in conversion rates according to TB exposure risk using the tuberculin skin test (TST) and the QuantiFERON-TB Gold In-Tube (QFT-GIT), and to evaluate the reproducibility and within-subject variability of the QFT-GIT in South Korea.

Methods

Fifty-three HCWs were grouped according to their risk for TB exposure: group 1, high risk (n = 21); group 2, low risk (n = 32). Baseline and follow-up TSTs and QFT-GITs were performed from June 2009 to July 2011. Enzyme-linked immunosorbent assays (ELISAs) were repeated for the second QFT-GIT and a third QFT-GIT was performed after 8 weeks when discordant results of the second TST and QFT-GIT or a conversion or reversion were observed.

Results

No difference in the QFT-GIT conversion rate was evident between the two groups (15.4 vs. 6.5 %, p = 0.57), and no TST conversion was observed. The rate of QFT-GIT positivity was higher in the high-risk group (first QFT-GIT: 38.1 vs. 3.1 %, p = 0.002; second QFT-GIT: 33.3 vs. 9.4 %, p = 0.039). The re-test reproducibility of QFT-GIT results was high (100 %), and the within-subject results of repetitive QFT-GITs were variable.

Conclusions

Stricter prevention strategies remain necessary in HCWs at high risk of TB exposure, and serial interferon-γ release assays (IGRAs) should be interpreted with caution in HCWs.
Literatur
1.
Zurück zum Zitat Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med. 1995;332:92–8.PubMedCrossRef Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med. 1995;332:92–8.PubMedCrossRef
2.
Zurück zum Zitat Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis. 2007;11:593–605.PubMed Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis. 2007;11:593–605.PubMed
3.
Zurück zum Zitat Jensen PA, Lambert LA, Iademarco MF, Ridzon R; CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54:1–141.PubMed Jensen PA, Lambert LA, Iademarco MF, Ridzon R; CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54:1–141.PubMed
4.
Zurück zum Zitat Sepulveda RL, Ferrer X, Latrach C, Sorensen RU. The influence of Calmette–Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis. 1990;142:24–8.PubMedCrossRef Sepulveda RL, Ferrer X, Latrach C, Sorensen RU. The influence of Calmette–Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis. 1990;142:24–8.PubMedCrossRef
5.
Zurück zum Zitat Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis. 1993;17:968–75.PubMedCrossRef Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis. 1993;17:968–75.PubMedCrossRef
6.
Zurück zum Zitat Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804–9.PubMedCrossRef Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804–9.PubMedCrossRef
7.
Zurück zum Zitat Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999;159:15–21.PubMedCrossRef Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999;159:15–21.PubMedCrossRef
8.
Zurück zum Zitat Pai M, Zwerling A, Menzies D. Systematic review: t-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177–84.PubMedCrossRef Pai M, Zwerling A, Menzies D. Systematic review: t-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177–84.PubMedCrossRef
9.
Zurück zum Zitat Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4:761–76.PubMedCrossRef Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4:761–76.PubMedCrossRef
10.
Zurück zum Zitat Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340–54.PubMedCrossRef Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340–54.PubMedCrossRef
11.
Zurück zum Zitat Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recomm Rep. 2010;59:1–25.PubMed Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recomm Rep. 2010;59:1–25.PubMed
12.
Zurück zum Zitat Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlösser S, Schultze-Werninghaus G, et al. Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clin Vaccine Immunol. 2011;18:1176–82.PubMedCrossRef Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlösser S, Schultze-Werninghaus G, et al. Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clin Vaccine Immunol. 2011;18:1176–82.PubMedCrossRef
13.
Zurück zum Zitat van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, et al. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med. 2009;180:49–58.PubMedCrossRef van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, et al. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med. 2009;180:49–58.PubMedCrossRef
14.
Zurück zum Zitat World Health Organization (WHO). Global tuberculosis control: WHO report 2011. WHO/HTM/TB/2011.16. Geneva, Switzerland: WHO. 2011. World Health Organization (WHO). Global tuberculosis control: WHO report 2011. WHO/HTM/TB/2011.16. Geneva, Switzerland: WHO. 2011.
15.
Zurück zum Zitat Jo KW, Woo JH, Hong Y, Choi CM, Oh YM, Lee SD, et al. Incidence of tuberculosis among health care workers at a private university hospital in South Korea. Int J Tuberc Lung Dis. 2008;12:436–40.PubMed Jo KW, Woo JH, Hong Y, Choi CM, Oh YM, Lee SD, et al. Incidence of tuberculosis among health care workers at a private university hospital in South Korea. Int J Tuberc Lung Dis. 2008;12:436–40.PubMed
16.
Zurück zum Zitat Kim SJ, Lee SH, Kim IS, Kim HJ, Kim SK, Rieder HL. Risk of occupational tuberculosis in National Tuberculosis Programme laboratories in Korea. Int J Tuberc Lung Dis. 2007;11:138–42.PubMed Kim SJ, Lee SH, Kim IS, Kim HJ, Kim SK, Rieder HL. Risk of occupational tuberculosis in National Tuberculosis Programme laboratories in Korea. Int J Tuberc Lung Dis. 2007;11:138–42.PubMed
17.
Zurück zum Zitat Joint Committee for the Development of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis, 1st edition 2011. Joint Committee for the Development of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis, 1st edition 2011.
18.
Zurück zum Zitat Lee KJ, Kang YA, Kim YM, Cho SN, Moon JW, Park MS, et al. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay. Scand J Infect Dis. 2010;42:672–8.CrossRef Lee KJ, Kang YA, Kim YM, Cho SN, Moon JW, Park MS, et al. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay. Scand J Infect Dis. 2010;42:672–8.CrossRef
19.
Zurück zum Zitat American Thoracic Society, CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000;16:S221–47. American Thoracic Society, CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000;16:S221–47.
20.
Zurück zum Zitat Lee K, Han MK, Choi HR, Choi CM, Oh YM, Lee SD, et al. Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital. Infect Control Hosp Epidemiol. 2009;30:1218–22.PubMedCrossRef Lee K, Han MK, Choi HR, Choi CM, Oh YM, Lee SD, et al. Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital. Infect Control Hosp Epidemiol. 2009;30:1218–22.PubMedCrossRef
21.
Zurück zum Zitat Park HY, Jeon K, Suh GY, Kwon OJ, Chung DR, Yoonchang SW, et al. Interferon-gamma release assay for tuberculosis screening of healthcare workers at a Korean tertiary hospital. Scand J Infect Dis. 2010;42:943–5.PubMedCrossRef Park HY, Jeon K, Suh GY, Kwon OJ, Chung DR, Yoonchang SW, et al. Interferon-gamma release assay for tuberculosis screening of healthcare workers at a Korean tertiary hospital. Scand J Infect Dis. 2010;42:943–5.PubMedCrossRef
22.
Zurück zum Zitat Skodric-Trifunovic V, Markovic-Denic L, Nagorni-Obradovic L, Vlajinac H, Woeltje KF. The risk of occupational tuberculosis in Serbian health care workers. Int J Tuberc Lung Dis. 2009;13:640–4.PubMed Skodric-Trifunovic V, Markovic-Denic L, Nagorni-Obradovic L, Vlajinac H, Woeltje KF. The risk of occupational tuberculosis in Serbian health care workers. Int J Tuberc Lung Dis. 2009;13:640–4.PubMed
23.
Zurück zum Zitat Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med. 2006;174:349–55.PubMedCrossRef Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med. 2006;174:349–55.PubMedCrossRef
24.
Zurück zum Zitat Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, Lugos MD, et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 2007;4:e192.PubMedCrossRef Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, Lugos MD, et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 2007;4:e192.PubMedCrossRef
25.
Zurück zum Zitat Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, Lee SM, et al. Monthly follow-ups of interferon-gamma release assays among healthcare workers in contact with TB patients. Chest. 2012. doi:10.1378/chest.11-3299. Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, Lee SM, et al. Monthly follow-ups of interferon-gamma release assays among healthcare workers in contact with TB patients. Chest. 2012. doi:10.​1378/​chest.​11-3299.
26.
Zurück zum Zitat Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EE, Reddy MV, et al. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One. 2008;3:e1850.PubMedCrossRef Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EE, Reddy MV, et al. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One. 2008;3:e1850.PubMedCrossRef
27.
Zurück zum Zitat Detjen AK, Loebenberg L, Grewal HM, Stanley K, Gutschmidt A, Kruger C, et al. Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol. 2009;16:1170–5.PubMedCrossRef Detjen AK, Loebenberg L, Grewal HM, Stanley K, Gutschmidt A, Kruger C, et al. Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol. 2009;16:1170–5.PubMedCrossRef
28.
Zurück zum Zitat Grindulis H, Baynham MI, Scott PH, Thompson RA, Wharton BA. Tuberculin response two years after BCG vaccination at birth. Arch Dis Child. 1984;59:614–9.PubMedCrossRef Grindulis H, Baynham MI, Scott PH, Thompson RA, Wharton BA. Tuberculin response two years after BCG vaccination at birth. Arch Dis Child. 1984;59:614–9.PubMedCrossRef
29.
Zurück zum Zitat Hadfield JW, Allan J, Windebank WJ. Sensitivity of neonates to tuberculin after BCG vaccination. Br Med J (Clin Res Ed). 1986;292:990–1.CrossRef Hadfield JW, Allan J, Windebank WJ. Sensitivity of neonates to tuberculin after BCG vaccination. Br Med J (Clin Res Ed). 1986;292:990–1.CrossRef
Metadaten
Titel
Conversion rates of an interferon-γ release assay and the tuberculin skin test in the serial monitoring of healthcare workers
verfasst von
S. Y. Kim
M. S. Park
Y. S. Kim
S. K. Kim
J. Chang
Y. A. Kang
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 2/2013
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0356-0

Weitere Artikel der Ausgabe 2/2013

Infection 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.